Sicily, Italy

Andrea Pace

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The University of Texas System, University of Palermo. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrea Pace. Retrieved from https://idiyas.com/inventor/andrea-pace-162zuhxk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrea Pace: Innovator in Tau Oligomer Modulation

Introduction

Andrea Pace is a notable inventor based in Sicily, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of small molecules that target tau oligomers. His work is crucial in understanding and potentially treating neurodegenerative diseases.

Latest Patents

Andrea Pace holds a patent for "Small molecules that bind and/or modulate different forms of tau oligomers." This invention relates to novel small molecules of Formulas I, II, III, Ilia, Illb, and IV, along with their pharmaceutically acceptable salts. The preparation and use of these molecules could have important implications in medical science.

Career Highlights

Throughout his career, Andrea has worked with prestigious institutions such as the University of Texas System and the University of Palermo. His academic background and research experience have positioned him as a key figure in his field.

Collaborations

Andrea has collaborated with notable colleagues, including Rakez Kayed and Filippa Lo Cascio. Their combined expertise has contributed to advancements in research related to tau oligomers.

Conclusion

Andrea Pace's innovative work in the modulation of tau oligomers showcases his commitment to advancing medical science. His contributions are paving the way for future research and potential treatments for neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…